PROfiling Based Endometrial Cancer Adjuvant Therapy

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2022
This is a prospective, multicenter, randomized phase III trial among women with endometrioid adenocarcinoma with high-intermediate and intermediate risk features to investigate the role of integrated genomic-pathologic classification to determine if participants should receive no adjuvant therapy, vaginal brachytherapy, external beam radiotherapy or chemo-radiation therapy based on molecular features as compared to standard radiation therapy.
Epistemonikos ID: a4d4bc0bd4995dc274791a8562c041f24cd36ceb
First added on: May 09, 2024